News for Charles River Laboratories Stock (CRL)

Charles River (CRL) to Advance DNA Programs With New Launch

Zacks Investment Research • 01/13/23

Should You Buy Charles River Laboratories (CRL) After Golden Cross?

Zacks Investment Research • 01/12/23

Charles River Establishes eXpDNA™ Plasmid Manufacturing Platform to Expedite DNA Programs

Business Wire • 01/12/23

Arlington Capital Partners Announces the Acquisition of AVS Bio

Business Wire • 01/05/23

Charles River (CRL) Benefits From Price Rise Amid FX Woe

Zacks Investment Research • 12/20/22

Charles River Laboratories Adds Craig B. Thompson, M.D.

Business Wire • 12/06/22

Charles River Launches Endosafe Nexus 200, Emphasizes Critical Importance of Smart Automation for Endotoxin Detection

Business Wire • 12/01/22

Charles River Laboratories Opens Contract Vivarium Space in Chicago, Enhancing Access to AAALAC-Accredited, Turnkey Research Program

Business Wire • 11/28/22

Charles River Laboratories to Present at November Investor Conferences

Business Wire • 11/14/22

Charles River Laboratories Demonstrates Excellence in Advanced Modalities at Neuroscience 2022

Business Wire • 11/10/22

Charles River Announces Cell Therapy Manufacturing Capacity Expansion, Reinforcing Commitment to CDMO Clients

Business Wire • 11/07/22

Charles River Laboratories International, Inc. (CRL) Q3 2022 Earnings Call Transcript

Seeking Alpha • 11/02/22

Charles River (CRL) Q3 Earnings Top Estimates, Margins Dip

Zacks Investment Research • 11/02/22

Why Charles River Laboratories Stock Is Jumping Today

The Motley Fool • 11/02/22

Charles River Laboratories (CRL) Tops Q3 Earnings and Revenue Estimates

Zacks Investment Research • 11/02/22

Charles River Laboratories Announces Third-Quarter 2022 Results

Business Wire • 11/02/22

Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for

Zacks Investment Research • 10/26/22

Charles River Launches HemaCare Donor App to Engage Diverse Donors and Source Cell Solutions for Critical Cell and Gene Therapy Research

Business Wire • 10/19/22

Charles River Laboratories: Near-Term Headwinds Outweigh Long-Term Tailwinds

Seeking Alpha • 10/18/22

Charles River and Nanoscope Therapeutics Announce Multifaceted Gene Therapy Manufacturing Partnership

Business Wire • 10/18/22

Charles River Laboratories Schedules Third-Quarter 2022 Earnings Release and Conference Call

Business Wire • 10/11/22

Charles River's (CRL) New Launch to Boost Gene Therapy Workflow

Zacks Investment Research • 10/11/22

Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs

Business Wire • 10/10/22

Dynamo Software Appoints New CTO From Charles River® to Lead FinTech Strategy, Engineering & Integration

Business Wire • 09/28/22

Charles River (CRL) Gains From Growing Demand Amid Macro Woes

Zacks Investment Research • 09/21/22